3-[[6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one, tris(2-hydroxyethyl) ether
3-[[6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one, tris(2-hydroxyethyl) ether Basic information
- Product Name:
- 3-[[6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one, tris(2-hydroxyethyl) ether
- Synonyms:
-
- 3-[[6-O-(6-Deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one,tris(2-hydroxyethyl) ether
- CAS:
- 31511-30-5
- MF:
- C33H42O19
- MW:
- 0
- EINECS:
- 250-670-5
- Mol File:
- 31511-30-5.mol
More
Less
3-[[6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one, tris(2-hydroxyethyl) ether Usage And Synthesis
Application
Clinically applicable to hemiplegia and aphasia caused by cerebral thrombosis and cerebral embolism, as well as pre-myocardial infarction syndrome, arteriosclerosis, central retinitis, thrombophlebitis, varicose veins, and edema caused by increased vascular permeability.
More
Less
3-[[6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one, tris(2-hydroxyethyl) ether(31511-30-5)Related Product Information
- 3',4',7-TRIMETHOXYFLAVONE
- Rutin
- KAEMPFEROL-3-O-RUTINOSIDE
- ISOQUERCITRIN
- Isorhamnetin
- QUERCETIN-3,7,3',4'-TETRAMETHYL ETHER
- TAMARIXETIN
- ASTRAGALIN
- ISORHAMNETIN-3-RUTINOSIDE
- ISORHAMNETIN-3-GLUCOSIDE
- 3,4'-DIMETHOXY-3',5,7-TRIHYDROXYFLAVONE
- Rhamnetin
- KAEMPFEROL-3,7,4'-TRIMETHYL ETHER
- Salidroside
- 3,4-DIMETHOXY-3,5,7-TRIHYDROXYFLAVONE
- 3,5-DIHYDROXY-7-METHOXY-2-(4-METHOXY-PHENYL)-CHROMEN-4-ONE
- REYNOUTRIN
- 4',7-DIMETHOXY-3,3',5-TRIHYDROXYFLAVONE